Efectos metabólicos del ayuno intermitente en pacientes adultos con síndrome metabólico
DOI:
https://doi.org/10.23857/dc.v9i3.3421Palabras clave:
Ayuno Intermitente, Ayuno, Síndrome Metabólico, AdultoResumen
El síndrome metabólico incluye varias alteraciones que ponen en riesgo la vida, por la relación con diferentes comorbilidades y complicaciones, actualmente ha surgido el ayuno intermitente como una nueva estrategia dietética. Al ser un nuevo modelo se quiere de ampliar la información, ya que se vivimos en un mundo globalizado donde se tiende a imitar conductas sin conocer a profundidad los principios e impacto de su aplicación. Por lo cual, el objetivo general es describir los efectos metabólicos del ayuno intermitente en pacientes adultos con síndrome metabólico. La metodología utilizada para el presente trabajo de investigación, se enmarca dentro de una revisión narrativa a través de una búsqueda avanzada en bases de datos indexadas de alto impacto como Pubmed y Scopus desde el 2018 al 2023. De acuerdo a la información analizada se evidenció que la aplicación del ayuno intermitente provocó cuatro principales efectos metabólicos que abarcan la pérdida de peso, disminución sérica de triglicéridos, lipoproteínas de baja densidad, insulina- glucosa y presión arterial. Por lo tanto, la aplicación del ayuno es una buena alternativa en pacientes con alteraciones metabólicas, sin embargo, se requieren más estudios con población significativa.
Citas
Fahed G, Aoun L, Zerdan MB, Allam S, Zerdan MB, Bouferraa Y, et al. Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. Int J Mol Sci. 2022;23(2). Available from: https://pubmed.ncbi.nlm.nih.gov/35054972/
Vrdoljak J, Kumric M, Vilovic M, Martinovic D, Rogosic V, Borovac JA, et al. Can Fasting Curb the Metabolic Syndrome Epidemic? Nutrients. 2022;14(3). Available from: https://pubmed.ncbi.nlm.nih.gov/35276815/
Vasim I, Majeed CN, DeBoer MD. Intermittent Fasting and Metabolic Health. Nutrients. 2022;14(3). Available from: https://pubmed.ncbi.nlm.nih.gov/35276989/
Ortega Reyes VÁ, Ocampo Moreira PO, Ortega Reyes MD, Rodríguez Velásquez VK. Síndrome metabólico y factores de riesgo en adolescentes de la Unidad Educativa 29 de Agosto, periodo lectivo 2017 – 2018 Mata de Cacao/ los Ríos. RECIMUNDO. 2021;5(1):129–40. Available from: https://recimundo.com/index.php/es/article/view/992
De Filippo G. Obesidad y síndrome metabólico. EMC - Pediatría. 2021 Mar 1;56(1):1–7.
Peinado M, Dager I, Quintero K, Mogollón M, Puello A. Síndrome metabólico en adultos: Revisión narrativa de la literatura. Arch Med. 2021;17(2):4. Available from: https://dialnet.unirioja.es/servlet/articulo?codigo=7848788&info=resumen&idioma=ENG
Guo Y, Luo S, Ye Y, Yin S, Fan J, Xia M. Intermittent Fasting Improves Cardiometabolic Risk Factors and Alters Gut Microbiota in Metabolic Syndrome Patients. J Clin Endocrinol Metab. 2021;106(1):64–79. Available from: https://pubmed.ncbi.nlm.nih.gov/33017844/
Crupi AN, Haase J, Brandhorst S, Longo VD. Periodic and Intermittent Fasting in Diabetes and Cardiovascular Disease. Curr Diab Rep. 2020;20(12). Available from: https://pubmed.ncbi.nlm.nih.gov/33301104/
Wang X, Li Q, Liu Y, Jiang H, Chen W. Intermittent fasting versus continuous energy-restricted diet for patients with type 2 diabetes mellitus and metabolic syndrome for glycemic control: A systematic review and meta-analysis of randomized controlled trials. Diabetes Res Clin Pract; 2021. Available from: https://pubmed.ncbi.nlm.nih.gov/34391831/
Rajpal A, Ismail-Beigi F. Intermittent fasting and ‘metabolic switch’: Effects on metabolic syndrome, prediabetes and type 2 diabetes. Diabetes, Obes Metab. 2020;22(9):1496–510. Available from: https://pubmed.ncbi.nlm.nih.gov/32372521/
Quintero Gutiérrez AG, González Rosendo G, Gutiérrez Trujillo J, Puga Díaz R, Villanueva Sánchez J. Prevalence of risk eating behaviors and metabolic syndrome in teenage school students of Morelos state. Nutr Hosp. 2018;35(4):796–804. Available from: https://pubmed.ncbi.nlm.nih.gov/30070866/
Zeng L, Li HR, Liu MW, Rao WM, He QQ. Effects of intermittent fasting on cardiometabolic risk factors in patients with metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials. Asia Pac J Clin Nutr. 2022;31(4):642–59. Available from: https://pubmed.ncbi.nlm.nih.gov/36576283/
Bovolini A, Garcia J, Andrade MA, Duarte JA. Metabolic Syndrome Pathophysiology and Predisposing Factors. Int J Sports Med. 2021;42(3):199–214. Available from: https://pubmed.ncbi.nlm.nih.gov/33075830/
Dong TA, Sandesara PB, Dhindsa DS, Mehta A, Arneson LC, Dollar AL, et al. Intermittent Fasting: A Heart Healthy Dietary Pattern? Am J Med. 2020;133(8):901–7. Available from: https://pubmed.ncbi.nlm.nih.gov/32330491/
Yuan X, Wang J, Yang S, Gao M, Cao L, Li X, et al. Effect of Intermittent Fasting Diet on Glucose and Lipid Metabolism and Insulin Resistance in Patients with Impaired Glucose and Lipid Metabolism: A Systematic Review and Meta-Analysis. Int J Endrocrinol. 2022;2022. Available from: https://pubmed.ncbi.nlm.nih.gov/35371260/
Rohner M, Heiz R, Feldhaus S, Bornstein SR. Hepatic-Metabolite-Based Intermittent Fasting Enables a Sustained Reduction in Insulin Resistance in Type 2 Diabetes and Metabolic Syndrome. Horm Metab Res. 2021;53(8):529–40. Available from: http://www.thieme-connect.de/products/ejournals/html/10.1055/a-1510-8896
Mindikoglu AL, Abdulsada MM, Jain A, Jalal PK, Devaraj S, Wilhelm ZR, et al. Intermittent fasting from dawn to sunset for four consecutive weeks induces anticancer serum proteome response and improves metabolic syndrome. Sci Rep. 2020;10(1). Available from: https://pubmed.ncbi.nlm.nih.gov/33110154/
Liu L, Chen W, Wu D, Hu F. Metabolic Efficacy of Time-Restricted Eating in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Clin Endocrinol Metab. 2022;107(12):3428–41. Available from: https://pubmed.ncbi.nlm.nih.gov/36190980/
Joaquim L, Faria A, Loureiro H, Matafome P. Benefits, mechanisms, and risks of intermittent fasting in metabolic syndrome and type 2 diabetes. J Physiol Biochem. 2022;78(2):295–305. Available from: https://pubmed.ncbi.nlm.nih.gov/34985730/
Kunduraci YE, Ozbek H. Does the energy restriction intermittent fasting diet alleviate metabolic syndrome biomarkers? A randomized controlled trial. Nutrients. 2020;12(10):1–13. Available from: https://pubmed.ncbi.nlm.nih.gov/33096684/
Bartholomew CL, Muhlestein JB, May HT, Le VT, Galenko O, Garrett KD, et al. Randomized controlled trial of once-per-week intermittent fasting for health improvement: the WONDERFUL trial. Eur Hear J Open. 2021;1(2). Available from: https://pubmed.ncbi.nlm.nih.gov/35919268/
Sundfor TM, Svendsen M, Tonstad S. Effect of intermittent versus continuous energy restriction on weight loss, maintenance and cardiometabolic risk: A randomized 1-year trial. Nutr Metab Cardiovasc Dis. 2018;28(7):698–706. Available from: https://pubmed.ncbi.nlm.nih.gov/29778565/
Li C, Sadraie B, Steckhan N, Kessler C, Stange R, Jeitler M, et al. Effects of A One-week Fasting Therapy in Patients with Type-2 Diabetes Mellitus and Metabolic Syndrome - A Randomized Controlled Explorative Study. Exp Clin Endocrinol Diabetes. 2019;125(9):618–24. Available from: https://pubmed.ncbi.nlm.nih.gov/28407662/
Tahreem A, Rakha A, Rabail R, Nazir A, Socol CT, Maerescu CM, et al. Fad Diets: Facts and Fiction. Front Nutr. 2022;9. Available from: /pmc/articles/PMC9294402/
Jospe MR, Roy M, Brown RC, Haszard JJ, Meredith-Jones K, Fangupo LJ, et al. Intermittent fasting, Paleolithic, or Mediterranean diets in the real world: Exploratory secondary analyses of a weight-loss trial that included choice of diet and exercise. Am J Clin Nutr. 2020;111(3):503–14. Available from: https://pubmed.ncbi.nlm.nih.gov/31879752/
Erdem NZ, Bayraktaro?lu E, Samanc? RA, Geçgil-Demir E, Tarakç? NG, Mert-Bibero?lu F. The effect of intermittent fasting diets on body weight and composition. Clin Nutr ESPEN. 2022;51:207–14. Available from: https://pubmed.ncbi.nlm.nih.gov/36184206/
Jahrami H, Trabelsi K, Alhaj OA, Saif Z, Pandi-Perumal SR, BaHammam AS. The impact of Ramadan fasting on the metabolic syndrome severity in relation to ethnicity and sex: Results of a systematic review and meta-analysis. Nutr Metab Cardiovasc Dis. 2022;32(12):2714–29. Available from: https://pubmed.ncbi.nlm.nih.gov/36333203/
Gray KL, Clifton PM, Keogh JB, Keogh JB. The effect of intermittent energy restriction on weight loss and diabetes risk markers in women with a history of gestational diabetes: a 12-month randomized control trial. Am J Clin Nutr. 2021;114(2):794–803. Available from: https://pubmed.ncbi.nlm.nih.gov/33831950/
Carter S, Clifton PM, Keogh JB. Effect of Intermittent Compared With Continuous Energy Restricted Diet on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Noninferiority Trial. JAMA Netw open. 2018;1(3):e180756. Available from: /pmc/articles/PMC6324303/
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2023 Cinthya Anabel Muyulema Chimbo, Gina Fabiola Mora Dominguez
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Authors retain copyright and guarantee the Journal the right to be the first publication of the work. These are covered by a Creative Commons (CC BY-NC-ND 4.0) license that allows others to share the work with an acknowledgment of the work authorship and the initial publication in this journal.
